Cargando…
Synthetic lethals in HIV: ways to avoid drug resistance: Running title: Preventing HIV resistance
BACKGROUND: RNA viruses rapidly accumulate genetic variation, which can give rise to synthetic lethal (SL) and deleterious (SD) mutations. Synthetic lethal mutations (non-lethal when alone but lethal when combined in one genome) have been studied to develop cancer therapies. This principle can also...
Autores principales: | Petitjean, Michel, Badel, Anne, Veitia, Reiner A, Vanet, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4399722/ https://www.ncbi.nlm.nih.gov/pubmed/25888435 http://dx.doi.org/10.1186/s13062-015-0044-y |
Ejemplares similares
-
Co-lethality studied as an asset against viral drug escape: the HIV protease case
por: Brouillet, Sophie, et al.
Publicado: (2010) -
VIRAPOPS2 supports the influenza virus reassortments
por: Petitjean, Michel, et al.
Publicado: (2014) -
Structural Impacts of Drug-Resistance Mutations Appearing in HIV-2 Protease
por: Laville, Pierre, et al.
Publicado: (2021) -
Impacts of drug resistance mutations on the structural asymmetry of the HIV-2 protease
por: Laville, Pierre, et al.
Publicado: (2020) -
749. Interactive Technologies for Preventing HIV in Title X Clinics in Metropolitan Atlanta
por: Aldredge, Amalia, et al.
Publicado: (2023)